Immatics N.V. (IMTX) Financial Ratios
8 years of historical data (2018–2025) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: 12.65
30Y Low12.7·High12.7
P/FCF
N/A
—
5yr avg: 6.38
30Y Low6.4·High30.6
P/B Ratio
↓
2.16
↓-76% vs avg
5yr avg: 9.14
30Y Low1.3·High35.1
ROE
↑
-37.1%
↓+4% vs avg
5yr avg: -38.8%
30Y Low-148%·High32%
Debt/EBITDA
N/A
—
5yr avg: 0.40
30Y Low0.4·High0.4
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
IMTX Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Immatics N.V. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.3B | $1.3B | $759M | $848M | $599M | $846M | $518M | $654M | $617M |
| Enterprise Value | $934M | $955M | $539M | $645M | $466M | $722M | $317M | $554M | $577M |
| P/E Ratio → | -5.55 | — | 50.79 | — | 16.13 | — | — | — | — |
| P/S Ratio | 23.74 | 26.62 | 4.87 | 15.71 | 3.47 | 24.32 | 16.57 | 35.46 | 163.53 |
| P/B Ratio | 2.16 | 2.65 | 1.32 | 3.77 | 2.81 | 35.14 | 4.97 | — | — |
| P/FCF | — | — | — | — | 6.38 | — | — | 9.52 | 30.55 |
| P/OCF | — | — | — | 46.53 | 5.99 | — | — | 9.22 | 29.81 |
P/E links to full P/E history page with 30-year chart
IMTX EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 19.78 | 3.46 | 11.95 | 2.69 | 20.78 | 10.13 | 30.04 | 153.09 |
| EV / EBITDA | — | — | — | — | 12.65 | — | — | — | — |
| EV / EBIT | — | — | 24.23 | — | 10.81 | — | — | — | — |
| EV / FCF | — | — | — | — | 4.96 | — | — | 8.06 | 28.60 |
IMTX Profitability
Margins and return-on-capital ratios measuring operating efficiency
Immatics N.V. earns an operating margin of -377.1%. Operating margins have compressed from -188.4% to -377.1% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -37.1% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 100.0% | 100.0% | 100.0% | -119.8% | 38.2% | -151.9% | -114.7% | -117.3% | -801.1% |
| Operating Margin | -377.1% | -377.1% | -24.8% | -188.4% | 17.3% | -248.2% | -223.1% | -178.9% | -912.7% |
| Net Profit Margin | -407.0% | -407.0% | 9.8% | -179.6% | 21.7% | -273.5% | -733.8% | -172.0% | -834.1% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -37.1% | -37.1% | 3.8% | -44.3% | 31.6% | -148.2% | -723.3% | — | — |
| ROA | -31.2% | -31.2% | 2.5% | -21.1% | 12.9% | -44.3% | -117.9% | -32.5% | -51.3% |
| ROIC | -53.7% | -53.7% | -15.4% | -150.7% | 28.4% | — | — | — | — |
| ROCE | -31.7% | -31.7% | -7.9% | -31.1% | 15.7% | -63.1% | -53.8% | -66.4% | -99.8% |
IMTX Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $346M exceeds total debt of $16M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.03 | 0.03 | 0.03 | 0.07 | 0.07 | 0.41 | 0.06 | — | — |
| Debt / EBITDA | — | — | — | — | 0.40 | — | — | — | — |
| Net Debt / Equity | — | -0.68 | -0.38 | -0.90 | -0.63 | -5.12 | -1.93 | — | — |
| Net Debt / EBITDA | — | — | — | — | -3.64 | — | — | — | — |
| Debt / FCF | — | — | — | — | -1.43 | — | — | -1.46 | -1.95 |
| Interest Coverage | -208.76 | -208.76 | 25.09 | -115.72 | 41.50 | -163.90 | -732.01 | -190.10 | -2021.19 |
Net cash position: cash ($346M) exceeds total debt ($16M)
IMTX Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Immatics N.V.'s current ratio of 11.72x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 2.87x to 11.72x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.72 | 11.72 | 9.26 | 2.87 | 3.54 | 1.60 | 3.94 | 1.79 | 2.06 |
| Quick Ratio | 11.72 | 11.72 | 9.26 | 2.87 | 3.54 | 1.60 | 3.89 | 1.77 | 2.06 |
| Cash Ratio | 10.91 | 10.91 | 8.89 | 2.72 | 3.40 | 1.53 | 3.83 | 1.72 | 1.95 |
| Asset Turnover | — | 0.09 | 0.22 | 0.11 | 0.42 | 0.20 | 0.12 | 0.14 | 0.06 |
| Inventory Turnover | — | — | — | — | — | — | 20.31 | 32.44 | — |
| Days Sales Outstanding | — | 52.01 | 15.80 | 38.78 | 2.35 | 24.77 | 34.14 | 53.87 | 176.01 |
IMTX Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Immatics N.V. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 2.0% | — | 6.2% | — | — | — | — |
| FCF Yield | — | — | — | — | 15.7% | — | — | 10.5% | 3.3% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $122M | $107M | $81M | $69M | $63M | $48M | $63M | $63M |
Peer Comparison
Compare IMTX with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 IMTXYou | $1B | -5.5 | — | — | 100.0% | -377.1% | -37.1% | -53.7% | — |
 TCRT | $5M | -1.0 | — | — | 100.0% | -84500.0% | -198.1% | -364.2% | — |
 AGEN | $127M | -894.1 | — | — | 29.6% | -18.0% | — | — | — |
 FATE | $251M | -1.9 | — | — | -94.1% | -2222.4% | -51.8% | -36.5% | — |
 CRIS | $83M | -0.7 | — | — | 99.5% | -348.4% | -138.8% | — | — |
 NKTX | $200M | -2.0 | — | — | — | — | -28.9% | -22.5% | — |
 KYMR | $8B | -27.0 | — | — | 100.0% | -891.3% | -25.8% | -24.9% | — |
 RCUS | $3B | -8.3 | — | — | 96.0% | -156.3% | -63.3% | -64.1% | — |
 IMVT | $8B | -13.8 | — | — | — | — | -64.8% | — | — |
 TGTX | $8B | 19.6 | 68.9 | — | 83.7% | 20.0% | 102.8% | 16.4% | 2.1 |
 MGNX | $291M | -3.9 | — | — | 71.1% | -48.7% | -86.9% | -144.1% | — |
| Healthcare Median | — | 22.1 | 14.2 | 18.4 | 63.9% | -4.4% | -33.2% | -11.7% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 8 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
IMTX — Frequently Asked Questions
Quick answers to the most common questions about buying IMTX stock.
What is Immatics N.V.'s P/E ratio?
Immatics N.V.'s current P/E ratio is -5.5x. The historical average is 33.5x.
What is Immatics N.V.'s ROE?
Immatics N.V.'s return on equity (ROE) is -37.1%. The historical average is -38.8%.
Is IMTX stock overvalued?
Based on historical data, Immatics N.V. is trading at a P/E of -5.5x. Compare with industry peers and growth rates for a complete picture.
What are Immatics N.V.'s profit margins?
Immatics N.V. has 100.0% gross margin and -377.1% operating margin.